Jun 1, 2026 08:01AM
Jun 1, 2026 08:00AM
Apr 7, 2026 07:31AM
Mar 31, 2026 06:45AM
Mar 31, 2026 06:45AM
Jan 14, 2026 05:01PM
Jan 14, 2026 05:00PM Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annu
Dec 22, 2025 07:06AM
Dec 11, 2025 07:00AM
Dec 11, 2025 07:00AM
Nov 5, 2025 07:00AM
Oct 24, 2025 08:29AM
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
Aug 12, 2025 07:00AM
Jun 16, 2025 09:00AM
Jan 8, 2025 07:06AM
Jan 8, 2025 07:05AM
Nov 12, 2024 07:00AM
Sep 26, 2024 06:01AM
Sep 26, 2024 06:00AM Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)
Sep 10, 2024 07:00AM
Sep 10, 2024 07:00AM
Aug 27, 2024 08:10AM
Aug 27, 2024 08:00AM
Aug 13, 2024 07:00AM
May 13, 2024 04:10PM
Apr 22, 2024 07:00AM Centessa Pharmaceuticals (CNTA) Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
Apr 22, 2024 07:00AM
Mar 28, 2024 04:28PM
Feb 26, 2024 07:00AM
Feb 9, 2024 07:00AM
Dec 11, 2023 03:50AM
Dec 10, 2023 12:05PM
Nov 13, 2023 04:05PM Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2023
Nov 2, 2023 09:09AM
Oct 31, 2023 08:00AM
Aug 14, 2023 07:00AM
Jul 10, 2023 08:00AM
May 22, 2023 07:00AM
May 22, 2023 07:00AM
May 12, 2023 07:00AM Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2023
Mar 30, 2023 07:06AM
Mar 30, 2023 07:00AM
Mar 30, 2023 07:00AM
Feb 6, 2023 08:00AM
Feb 6, 2023 08:00AM
Jan 26, 2023 09:08AM
Jan 26, 2023 09:08AM Centessa Pharmaceuticals Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of LB101, First LockBody® Candidate, for Solid Tumors
Jan 26, 2023 09:08AM

323,582 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All